La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Lyra Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Lyra Therapeutics..

Lyra Therapeutics (NASDAQ:LYRA) Azioni, Quote.MetaTitle.option-chain

Lyra Therapeutics

Panoramica

Notizie

Utili

Opzioni

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Comments

Lyra Therapeutics Catena di Opzioni

Opzioni

Lyra Therapeutics (NASDAQ:LYRA) Azioni, Quote.MetaTitle.option-chain

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO